Prakash Diwan of Altamount Capital Management recommends buying Sun Pharma Advanced Research Company with a target price of Rs 134.50 and stop loss at Rs 127.50.
first published: Jul 4, 2013 01:39 pm
A collection of the most-viewed Moneycontrol videos.
You are already a Moneycontrol Pro user.

